Paper Details 
Original Abstract of the Article :
The Pharmacokinetics and clinical effectiveness of cefdinir (CFDN, FK482) were examined in pediatric patients. The results are summarized as follows. 1. Plasma concentrations and urinary excretions of CFDN after administration of 5% fine granules were investigated on 4 children at a dose level of 6 ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1762171

データ提供:米国国立医学図書館(NLM)

Cefdinir: A New Hope for Pediatric Infections

This study explores the critical area of

pediatric infectious diseases

, focusing on the effectiveness and safety of cefdinir in treating bacterial infections in children. The researchers, like caring parents tending to their child's well-being, meticulously examined the pharmacokinetics, bacteriological effects, and clinical efficacy of cefdinir in a group of pediatric patients. Their findings revealed that cefdinir, given in fine granule form, was well tolerated and effective in treating a range of bacterial infections. This study provides valuable insights into the use of cefdinir as a safe and effective treatment option for children.

Cefdinir: A Powerful Ally for Pediatric Infections

This research highlights the potential of cefdinir as a valuable tool for treating bacterial infections in children. The study's findings, like a refreshing oasis in the desert of pediatric medicine, demonstrate the effectiveness and safety of cefdinir in treating a variety of bacterial infections. This research underscores the importance of developing safe and effective treatments for children, ensuring that they receive the best possible care.

Navigating Pediatric Infections: A Focus on Safety and Effectiveness

This study underscores the importance of prioritizing safety and efficacy in pediatric medication development. The researchers, like guardians protecting the health of a vulnerable population, meticulously examined the pharmacokinetics, bacteriological effects, and clinical efficacy of cefdinir in children. This study highlights the need for a focused approach to pediatric medication development, ensuring that treatments are tailored to the unique needs of children and designed to minimize potential risks.

Dr.Camel's Conclusion

This research provides valuable insights into the use of cefdinir as a safe and effective treatment option for bacterial infections in children. The study highlights the importance of developing pediatric medications that are specifically tailored to the unique needs of this vulnerable population.

Date :
  1. Date Completed 1992-02-12
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

1762171

DOI: Digital Object Identifier

1762171

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.